ResearcherMcGill University and Génome Québec Innovation CentreNo recent work listed

Rowa Bakadlag

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4221-3429; OpenAlex author ID A5067025865. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2019: 1 paper

Papers 1

The potential of dopamine receptor D2 (DRD2) as a therapeutic target for tackling pancreatic cancer. Co-author DOI 10.1080/14728222.2019.1606904 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yasser Riazalhosseini · 1 shared paper, 2019 · strength 0.14
- Paper The potential of dopamine receptor D2 (DRD2) as a therapeutic target for tackling pancreatic cancer. DOI 10.1080/14728222.2019.1606904 ↗
Pouria Jandaghi · 1 shared paper, 2019 · strength 0.14
- Paper The potential of dopamine receptor D2 (DRD2) as a therapeutic target for tackling pancreatic cancer. DOI 10.1080/14728222.2019.1606904 ↗
Jörg D. Hoheisel · 1 shared paper, 2019 · strength 0.14
- Paper The potential of dopamine receptor D2 (DRD2) as a therapeutic target for tackling pancreatic cancer. DOI 10.1080/14728222.2019.1606904 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.